Dyne Therapeutics (DYN) Stock Price, Quote, News & History

SPY767.81+0.60%QQQ720.73+1.54%BTC/USD—DIA518.96−0.03%GLD379.92−0.55%TLT79.65−0.50%

Premium

Dyne Therapeutics Inc (DYN) Stock Price, Quote, News & History

DYNNASDAQ

Trade with Public

$14.75

0.503.51%

Last update: Oct 19, 10:43 AM

$14.42

0.171.19%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$14.45

Volume / Avg.

978.30K / 2.89M

Day Range

$14.45 - $15.19

52 Wk Range

14.00 - 27.31

Market Cap

$2.75B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

17.79%

Days to Cover

9.01

Recent Dyne Therapeutics, Inc. News

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.

Vandana Singh

Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings

U.S. stocks fell Tuesday as health care lagged, while energy gained. ABM beat estimates; oil rose, and several biotech shares surged or plunged.

Avi Kapoor

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

U.S. stock futures fell as Novartis plunged 12.7% after pelacarsen’s Phase III trial missed its endpoint; other biotech stocks also declined.

Avi Kapoor

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

iSpecimen surged 27.9% premarket on a $4.5M Foldlab AI asset deal; CEA Industries led gainers, while Focus Universal plunged 51.2%.

Avi Kapoor

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Pegasystems Inc (NASDAQ: PEGA) reported lower-than-expected earnings and sales, causing stocks to fall 16% in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-477.82M

Investing Cash Flow (TTM)

-44.17M

Financing Cash Flow (TTM)

713.47M

Free Cash Flow (TTM)

-499.22M

Capital Expenditure (TTM)

-21.40M

Net Change in Cash (TTM)

191.48M

Analyst Trends and Forecast

May

Jun

Jul

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.98B

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

3.79

Earnings Yield % (TTM)

-22.89%

Earnings Yield % (FWD)

-22.57%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$3.76

Company Debt

Total Debt

$199.33M

LT Debt

$199.33M

LT Debt Issuance (TTM)

$98.90M

LT Debt Repayment (TTM)

Total Cash

$676.11M

Debt to Equity

0.31

Issuance of Debt (TTM)

$98.90M

Repayment of Debt (TTM)

Key Statistics

Open

$14.45

Volume / Avg.

978.30K / 2.89M

Day Range

$14.45 - $15.19

52 Wk Range

14.00 - 27.31

Market Cap

$2.75B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

17.79%

Days to Cover

9.01

About Dyne Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.

View our list of the best stock brokerages

Who are Dyne Therapeutics (DYN) competitors?

Other companies in Dyne Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

Dyne Therapeutics has a consensus price target of $38.00.

What is the current price for Dyne Therapeutics (DYN)?

The stock price for Dyne Therapeutics (NASDAQ: DYN) is $14.75 last updated October 19, 2026 at 10:43 AM EDT.

Does Dyne Therapeutics (DYN) pay a dividend?

There are no upcoming dividends for Dyne Therapeutics.

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Dyne Therapeutics does not have any upcoming earnings scheduled.

Is Dyne Therapeutics (DYN) going to split?

There is no upcoming split for Dyne Therapeutics.

What sector and industry does Dyne Therapeutics (DYN) operate in?

Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Dyne Therapeutics Inc (DYN) Stock Price, Quote, News & History

Dyne Therapeutics (DYN) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent Dyne Therapeutics, Inc. News

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About Dyne Therapeutics Inc

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

Who are Dyne Therapeutics (DYN) competitors?

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

What is the current price for Dyne Therapeutics (DYN)?

Does Dyne Therapeutics (DYN) pay a dividend?

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Is Dyne Therapeutics (DYN) going to split?

What sector and industry does Dyne Therapeutics (DYN) operate in?

Key Statistics

Recent Dyne Therapeutics, Inc. News

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Crude Oil Gains 1.5%; ABM Posts Upbeat Q3 Earnings

Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket

Pegasystems Posts Downbeat Q2 Results, Joins Adtran, Dyne Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About Dyne Therapeutics Inc

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

FAQ

How do I buy Dyne Therapeutics (DYN) stock?

Who are Dyne Therapeutics (DYN) competitors?

What is the forecast, or price target, for Dyne Therapeutics (DYN) stock?

What is the current price for Dyne Therapeutics (DYN)?

Does Dyne Therapeutics (DYN) pay a dividend?

When is Dyne Therapeutics (NASDAQ:DYN) reporting earnings?

Is Dyne Therapeutics (DYN) going to split?

What sector and industry does Dyne Therapeutics (DYN) operate in?

Bulls vs Bears